These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 20309872)
1. Synthesis and in-vitro cytotoxicity of poly-functionalized 4-(2-arylthiazol-4-yl)-4H-chromenes. Mahmoodi M; Aliabadi A; Emami S; Safavi M; Rajabalian S; Mohagheghi MA; Khoshzaban A; Samzadeh-Kermani A; Lamei N; Shafiee A; Foroumadi A Arch Pharm (Weinheim); 2010 Jul; 343(7):411-6. PubMed ID: 20309872 [TBL] [Abstract][Full Text] [Related]
2. 2-Amino-3-cyano-4-(5-arylisoxazol-3-yl)-4H-chromenes: synthesis and in vitro cytotoxic activity. Akbarzadeh T; Rafinejad A; Mollaghasem JM; Safavi M; Fallah-Tafti A; Pordeli M; Ardestani SK; Shafiee A; Foroumadi A Arch Pharm (Weinheim); 2012 May; 345(5):386-92. PubMed ID: 22266847 [TBL] [Abstract][Full Text] [Related]
3. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. Kemnitzer W; Drewe J; Jiang S; Zhang H; Wang Y; Zhao J; Jia S; Herich J; Labreque D; Storer R; Meerovitch K; Bouffard D; Rej R; Denis R; Blais C; Lamothe S; Attardo G; Gourdeau H; Tseng B; Kasibhatla S; Cai SX J Med Chem; 2004 Dec; 47(25):6299-310. PubMed ID: 15566300 [TBL] [Abstract][Full Text] [Related]
4. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2. Structure-activity relationships of the 7- and 5-, 6-, 8-positions. Kemnitzer W; Kasibhatla S; Jiang S; Zhang H; Zhao J; Jia S; Xu L; Crogan-Grundy C; Denis R; Barriault N; Vaillancourt L; Charron S; Dodd J; Attardo G; Labrecque D; Lamothe S; Gourdeau H; Tseng B; Drewe J; Cai SX Bioorg Med Chem Lett; 2005 Nov; 15(21):4745-51. PubMed ID: 16143530 [TBL] [Abstract][Full Text] [Related]
5. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high throughput screening assay. 4. Structure-activity relationships of N-alkyl substituted pyrrole fused at the 7,8-positions. Kemnitzer W; Drewe J; Jiang S; Zhang H; Crogan-Grundy C; Labreque D; Bubenick M; Attardo G; Denis R; Lamothe S; Gourdeau H; Tseng B; Kasibhatla S; Cai SX J Med Chem; 2008 Feb; 51(3):417-23. PubMed ID: 18197614 [TBL] [Abstract][Full Text] [Related]
6. Discovery of 4-aryl-2-oxo-2H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. Kemnitzer W; Jiang S; Zhang H; Kasibhatla S; Crogan-Grundy C; Blais C; Attardo G; Denis R; Lamothe S; Gourdeau H; Tseng B; Drewe J; Cai SX Bioorg Med Chem Lett; 2008 Oct; 18(20):5571-5. PubMed ID: 18805007 [TBL] [Abstract][Full Text] [Related]
7. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles. Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer. Doshi JM; Tian D; Xing C J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of 2-(5-((5-(4-chlorophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid derivatives and evaluation of their cytotoxicity and induction of apoptosis in human leukemia cells. Chandrappa S; Kavitha CV; Shahabuddin MS; Vinaya K; Ananda Kumar CS; Ranganatha SR; Raghavan SC; Rangappa KS Bioorg Med Chem; 2009 Mar; 17(6):2576-84. PubMed ID: 19243955 [TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro cytotoxicity and apoptosis inducing study of 2-aryl-3-nitro-2H-chromene derivatives as potent anti-breast cancer agents. Rahmani-Nezhad S; Safavi M; Pordeli M; Ardestani SK; Khosravani L; Pourshojaei Y; Mahdavi M; Emami S; Foroumadi A; Shafiee A Eur J Med Chem; 2014 Oct; 86():562-9. PubMed ID: 25216378 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives. Congiu C; Onnis V; Vesci L; Castorina M; Pisano C Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel chromene derivatives of expected antitumor activity. Kandeel MM; Kamal AM; Abdelall EK; Elshemy HA Eur J Med Chem; 2013 Jan; 59():183-93. PubMed ID: 23220647 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers. Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate. Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-tumor activities of N'-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone derivatives. Lou J; Liu Z; Li Y; Zhou M; Zhang Z; Zheng S; Wang R; Li J Bioorg Med Chem Lett; 2011 Nov; 21(22):6662-6. PubMed ID: 21986587 [TBL] [Abstract][Full Text] [Related]
16. Chromenes: potential new chemotherapeutic agents for cancer. Patil SA; Patil R; Pfeffer LM; Miller DD Future Med Chem; 2013 Sep; 5(14):1647-60. PubMed ID: 24047270 [TBL] [Abstract][Full Text] [Related]
17. 4-Aryl-4H-chromene-3-carbonitrile derivatives: evaluation of Src kinase inhibitory and anticancer activities. Fallah-Tafti A; Tiwari R; Shirazi AN; Akbarzadeh T; Mandal D; Shafiee A; Parang K; Foroumadi A Med Chem; 2011 Sep; 7(5):466-72. PubMed ID: 21801146 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, antitumor activity, and mechanism of action of benzo[a]pyrano[3,2-h]acridin-7-one analogues of acronycine. Nguyen TM; Sittisombut C; Boutefnouchet S; Lallemand MC; Michel S; Koch M; Tillequin F; Mazinghien R; Lansiaux A; David-Cordonnier MH; Pfeiffer B; Kraus-Berthier L; Léonce S; Pierré A J Med Chem; 2006 Jun; 49(11):3383-94. PubMed ID: 16722658 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers. Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro. Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]